Tim Brown: Move Forward With Pfizer

On Friday, the Packers signed Rodgers to a contract extension through the 2014 season. He's produced so far and was rewarded. However, in football, not all money is guaranteed, so while the length of the contract sounds impressive, the devil is in the details.

How does this parallel with my stock-picking philosophy? That's very simple. I look for performers and have no sentimental ties to any position because of what it has done for me in the past. I look ahead. Where will this stock take me going forward?

Pfizer at a Discount

Today I like Pfizer(PFE Quote). For the few of you who do not know this company, Pfizer engages in the discovery, development, manufacture and marketing of prescription drugs for people and animals. Some of its best-known drugs are Lipitor for cholesterol, Norvasc for hypertension and Caduet for cardiovascular problems.

This company is trading at a real discount. It closed on Friday at just $17.71, only a few bucks above its 52-week low of $14.31. In the last year, it's down more than 25%. Its forward price-to-earnings ratio is just 7.11. This metric is a measure of investor confidence in a particular stock. This stock is extremely undervalued. It has revenue of $48.87 billion and $26.18 billion in the bank.

Stocks overall have been banged up recently, but it appears some traders see a light at the end of the tunnel. With that said, it's still way too early to make any declarations about a return to normalcy. But a positive turn is always welcome.

Lastly, I like this stock because it should benefit from the strong dollar.

Keep moving the chains!